New-onset pulmonary tuberculosis in a patient with chronic obstructive pulmonary disease and coronary artery disease, angina pectoris: treatment options
- Authors: Bagisheva N.V1, Mordyk A.V1,2, Viktorova I.A1, Moiseeva M.V1, Sitnikova S.V3, Aroyan A.R1,4
-
Affiliations:
- Omsk State Medical University
- National Medical Research Center for Phthisiopulmonology and Infectious Diseases
- Clinical TB Dispensary №4
- Clinical TB Dispensary
- Issue: Vol 29, No 5 (2022)
- Pages: 66-69
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321004
- DOI: https://doi.org/10.18565/pharmateca.2022.5.66-69
- ID: 321004
Cite item
Open Access
Access granted
Abstract
Background. The importance of timely diagnosis of new-onset pulmonary tuberculosis (TB) in modern clinical practice is beyond doubt. Chronic obstructive pulmonary disease (COPD) and stable coronary artery disease (CAD, angina pectoris) mutually aggravate each other and worsen the patient’s condition, negatively affecting the prognosis. Description of the clinical case. The objective of the analysis of this clinical case included evaluation of the features of clinical manifestations, diagnostic tests and therapy in a patient with new-onset pulmonary TB and comorbid pulmonary-cardiac pathology: COPD and stable coronary artery disease (angina pectoris). In this clinical case, the patient had a combination of COPD and stable coronary artery disease (angina pectoris), and was also diagnosed with new-onset TB. The patient had general symptoms characteristic of TB, COPD and stable coronary artery disease (angina pectoris), characteristic changes in the results of laboratory and instrumental diagnostic methods. Treatment of new-onset TB was conducted according to regimen I at the settings of Clinical TB Dispensary. The patient took combined bronchodilator drugs: LAMA + LABA (tiotropium bromide/olodaterol); anti-ischemic therapy: non- dihydropyridine calcium antagonists (NDCA, verapamil) and trimetazidine. Conclusion. Against the background of anti-ischemic therapy with the use of NDCA and a myocardial cytoprotector (trimetazidine), the minimization of attacks of retrosternal pain with a sufficient rhythm-reducing effect was achieved.
Full Text
About the authors
N. V Bagisheva
Omsk State Medical UniversityOmsk, Russia
A. V Mordyk
Omsk State Medical University; National Medical Research Center for Phthisiopulmonology and Infectious DiseasesOmsk, Russia; Moscow, Russia
I. A Viktorova
Omsk State Medical UniversityOmsk, Russia
M. V Moiseeva
Omsk State Medical UniversityOmsk, Russia
S. V Sitnikova
Clinical TB Dispensary №4Omsk, Russia
A. R Aroyan
Omsk State Medical University; Clinical TB DispensaryOmsk, Russia
References
- Багишева, Н.В., Мордык А.В., Мордык Д.И. ХОБЛитуберкулез: существует ли связь? Медицинский вестник Северного Кавказа. 2019;1.1(14):135-40. @@Bagisheva, N.V., Mordyk A.V., Mordyk D.I. COPD and Tuberculosis: Is There a Link? Meditsinskii vestnik Severnogo Kavkaza. 2019;1.1(14):135-40. (In Russ.)
- Хроническая обструктивная болезнь легких. Клинические рекомендации. М., 2021. 94 с. @@Chronic obstructive pulmonary disease. Clinical recommendations. M., 2021. 94. р. (In Russ.)
- Оганов Р.Г., Денисов И.Н., Симаненков В.И. Коморбидная патология в клинической практике. Клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2017;6(16):5-56. @@Oganov R.G., Denisov I.N., Simanenkov V.I.Comorbid pathology in clinical practice. Clinical guidelines. Kardiovaskulyarnaya terapiya i profilaktika. 2017;6(16):5-56. (In Russ.)
- Стабильная ишемическая болезнь сердца. Клинические рекомендации. М., 2020. 75 с. @@Stable ischemic heart disease. Clinical guidelines. M., 2020. 75 p. (In Russ.)
- Фтизиатрия. Национальные клинические рекомендации. Под ред. П.К. Яблонского. М., 2015. 240 с. @@Phthisiology. National clinical guidelines. Ed. by PK. Yablonsky. M., 2015. 240р. (In Russ.).
- Драпкина О.М., Ливзан М.А., Мартынов А.И. и др. Первый Российский консенсус по количественной оценке приверженности к лечению: основные положения, алгоритмы и рекомендации. Медицинский вестник Северного Кавказа. 2018;13(1-2):259-71. @@Drapkina O.M., Livzan M.A., Martynov A.I., et al. First Russian consensus on quantifying adherence to treatment: basic provisions, algorithms and recommendations. Meditsinskii vestnik Severnogo Kavkaza. 2018;13(1-2):259-71. (In Russ.).
- Багишева Н.В., Мордык А.В, Викторова И.А., Трухан Д.И. Сердечно-сосудистая патология у пациентов с впервые выявленным туберкулезом и хронической обструктивной болезнью легких. Медицинский совет. 2021;14:142-48. @@Bagisheva N.V., Mordyk A.V, Viktorova I.A., Trukhan D.I. Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease. Meditsinskii sovet. 2021;14:142-48. (In Russ.).
- Викторова И.А., Багишева Н.В., Моисеева М.В. и др. Оптимизация гипотензивной терапии у коморбидных пациентов с туберкулезом легких, хронической обструктивной болезнью легких и артериальной гипертензией. Сибирское медицинское обозрение. 2020;122(2):36-44. @@Viktorova I.A., Bagisheva N.V., Moiseeva M.V, et al. Optimization of antihypertensive therapy in comorbid patients with pulmonary tuberculosis, chronic obstructive pulmonary disease and arterial hypertension. Sibirskoe meditsinskoe obozrenie. 2020; 122(2):36-44. (In Russ.).
- Викторова И.А., Багишева Н.В., Моисеева М.В. и др. Особенности терапии ишемической болезни сердца у пациентов с туберкулезом и хронической обструктивной болезнью легких. Русский медицинский журнал. 2021;29(1):10- @@Viktorova I.A., Bagisheva N.V., Moiseeva M.V, et al. Features of therapy for coronary heart disease in patients with tuberculosis and chronic obstructive pulmonary disease.Russkii meditsinskii zhurnal. 2021;29(1):10-6. (In Russ.).
Supplementary files
